ISSCR Comments on Horizon Europe

The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020. In its recommendations, the society prioritzied the following:
* an appropriate balance between basic and applied research;
* emphasis on scientific excellence in funding proposals;
* funding for basic research that involves human germline modification;
* increase in investment for biomedical research.

Please contact the ISSCR Policy Director, Eric Anthony with any questions about these comments or other policy and advocacy efforts.

Previous
Previous

ISSCR Applauds the FDA Announcement of New Guidelines for Cellular Therapies and Cell-based Tissue Products

Next
Next

ISSCR Opposes U.S. Restrictions on Fetal Tissue, Embryonic Stem Cell Research